Chemical activators of FOXD4L1 can influence its functional state through various cellular signaling pathways and mechanisms. Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C (PKC), which is known to phosphorylate transcription factors, potentially including FOXD4L1. This phosphorylation can lead to functional activation of FOXD4L1, as phosphorylation is a common mechanism for activating transcription factors. Similarly, forskolin raises intracellular cAMP levels, which subsequently activate protein kinase A (PKA). PKA then can phosphorylate transcription factors, thereby activating FOXD4L1. Ionomycin, by increasing intracellular calcium levels, leads to the activation of calmodulin-dependent kinase (CaMK), which can then phosphorylate FOXD4L1, causing its activation. A23187 also elevates intracellular calcium levels, thus activating kinases like CaMK that can phosphorylate and activate FOXD4L1.
Calyculin A and Okadaic Acid can maintain FOXD4L1 in a phosphorylated and activated state by inhibiting protein phosphatases that normally dephosphorylate transcription factors. Thapsigargin and Tunicamycin can induce endoplasmic reticulum stress, which can activate stress-activated protein kinases. These kinases are capable of phosphorylating and activating FOXD4L1. Anisomycin activates stress-activated protein kinases (SAPKs), which can also phosphorylate transcription factors such as FOXD4L1, leading to its functional activation. Bisindolylmaleimide I, as a PKC inhibitor, can lead to the compensatory activation of alternative kinases that may phosphorylate and activate FOXD4L1. In a similar vein, H-89 inhibits PKA, which could result in compensatory cellular responses that activate kinases capable of phosphorylating FOXD4L1. Finally, Epidermal Growth Factor (EGF) activates the EGF receptor, leading to the activation of MAPK/ERK signaling cascades. These cascades can phosphorylate transcription factors, including FOXD4L1, culminating in its activation. Each of these chemicals can act upon FOXD4L1 through distinct but converging pathways that involve the modification of FOXD4L1 or its regulatory proteins by phosphorylation, which is a critical post-translational modification for the activation of many transcription factors.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), and PKC has been shown to phosphorylate transcription factors. FOXD4L1 being a transcription factor could be functionally activated by PKC-mediated phosphorylation, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). CaMK can then phosphorylate and activate transcription factors such as FOXD4L1. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similar to Ionomycin, increasing intracellular calcium that activates kinases like CaMK which could then phosphorylate and activate FOXD4L1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, preventing dephosphorylation of proteins, which could lead to a sustained activation state of FOXD4L1 through its phosphorylated form. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid, by inhibiting protein phosphatases, maintains proteins in their phosphorylated state, potentially keeping FOXD4L1 in an activated form. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces endoplasmic reticulum stress and activates stress-activated protein kinases, which could phosphorylate and activate FOXD4L1. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin induces ER stress that can lead to activation of stress-activated kinases, which might then activate FOXD4L1 through phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which could phosphorylate transcription factors including FOXD4L1, leading to its activation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that could lead to compensatory activation of alternative kinases which might phosphorylate and activate FOXD4L1. | ||||||